MitoPrime (5-Amino-1MQ / MOTS-c / NAD+ Blend)

MitoPrime 120mg (5-Amino-1MQ / MOTS-c / NAD+ Blend)
Lyophilized Format • ≥99% HPLC Purity • Ships in 1–2 Business Days • U.S. Warehouses

MitoPrime is a 120mg mitochondrial support research blend combining three compounds studied for their roles in cellular energy metabolism and NAD+-linked pathways: 5-Amino-1MQ (10mg), MOTS-c (10mg), and NAD+ (100mg) per vial. 5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor studied in relation to NAD+ salvage pathway regulation and adipocyte metabolism. MOTS-c is a 16 amino acid mitochondrial-derived peptide encoded by the mitochondrial genome, studied for its role in AMPK activation and metabolic homeostasis. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular redox reactions and sirtuin-linked pathways. MitoPrime combines these three components into a single lyophilized vial for laboratories studying mitochondrial bioenergetics, NAD+ pathway interactions, and comparative metabolic research. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For laboratory research use only.

Compound Specifications

Why Research Laboratories Select MitoPrime

MitoPrime consolidates three independently-studied metabolic research compounds into a single blend, allowing laboratories to investigate NAD+ pathway regulation, mitochondrial-derived peptide signaling, and coenzyme-level bioenergetics without sourcing and reconstituting each compound separately.

• Combines an NNMT inhibitor, a mitochondrial-derived peptide, and a redox coenzyme in one lyophilized vial
• Each component has independent peer-reviewed research history (see below)
• Useful reference blend for comparative NAD+ salvage pathway and AMPK signaling research
• Lyophilized format ensures stability and reproducibility across experimental runs
• Batch and lot identifiers on all labeling for full laboratory documentation compliance

Research Background

Each component of MitoPrime has an independent research literature base. 5-Amino-1MQ has been studied as an NNMT inhibitor in the context of adipocyte metabolism and NAD+ salvage regulation (Neelakantan et al., 2018, ACS Medicinal Chemistry Letters). MOTS-c, a mitochondrial-derived peptide, has been studied for its role in AMPK-dependent metabolic regulation (Lee et al., 2015, Cell Metabolism). NAD+’s role in cellular redox chemistry and sirtuin activation is well established in the biochemistry literature. Note: the specific combination of these three compounds as a blend has not itself been the subject of published clinical or preclinical trials — the blend is offered as a research convenience product, and any pathway interactions between the three components in combination should be treated as an open research question rather than an established finding. MitoPrime is not FDA approved for any indication. All information provided here is for educational and reference purposes only and does not constitute medical or clinical guidance.

Shipping & Fulfillment

• Ships from U.S. warehouses — Florida, North Carolina, and California
• Overnight and 2-day shipping available at checkout
• Same-day processing on orders placed before 3:30 PM ET
• Discreet packaging with full tracking provided
• Bulk research orders welcome — contact us for volume pricing

Storage & Handling

• Store lyophilized peptide at -20°C away from light and moisture
• After reconstitution store at 2–8°C and use within 7 days
• Avoid repeated freeze-thaw cycles to maintain peptide integrity
• Handle using appropriate laboratory safety protocols
• Keep containers sealed when not in use

Frequently Asked Questions

For Research Use Only — Not for human or veterinary consumption • Not FDA approved for any indication • Supplied by Nextday Peptides for controlled in-vitro laboratory research use only